Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
All >

News > Switzerland

Total search results: 2185 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. 2018-12-03
Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. 2018-12-03
Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug. 2018-11-26
Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia, 2018-11-23
Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million". Pratteln & Allschwil. 2018-11-21
Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone". Pratteln & Allschwil. 2018-11-21
NBE Therapeutics AG. (11/15/18). "Press Release: Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE Therapeutics". Basel. 2018-11-15
Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. 2018-11-15
Roivant Sciences GmbH. (11/13/18). "Press Release: Roivant Sciences Announces $200 Million Investment Round". Basel & London. 2018-11-13
Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. 2018-11-12
Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. 2018-11-12
CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. 2018-11-09
CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-11-07
Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. 2018-11-06
Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. 2018-11-01
Novartis AG. (10/23/18). "Press Release: Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery". Fort Worth, TX. 2018-10-23
Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil. 2018-10-23
Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich. 2018-10-19
Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel. 2018-10-18
Novartis AG. (10/18/18). "Press Release: Novartis Announces Planned Acquisition of Endocyte to Expand Expertise in Radiopharmaceuticals and Build on Commitment to Transformational Therapeutic Platforms". Basel. 2018-10-18
Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. 2018-10-16
Sphingotec GmbH. (10/8/18). "Press Release: Sphingotec Raises €20 Million from HBM and Wellington Partners". Hennigsdorf. 2018-10-08
Genedata AG. (10/2/18). "Press Release: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors". Basel. 2018-10-02
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel. 2018-09-27
SGS S.A.. (9/26/18). "Press Release: SGS Issues CHF 225 Million and CHF 175 Million Bonds [NOT FOR DISTRIBUTION IN THE UNITED STATES et al.]". 2018-09-26
MaxiVax S.A.. (9/25/18). "Press Release: MaxiVax Starts Phase 2 Study in Switzerland of Innovative Cancer Vaccine in Patients with Head & Neck Cancer". Geneva. 2018-09-25
Aktiia S.A.. (9/25/18). "Press Release: Aktiia Closes 4M Seed Round to Reinvent Blood Pressure Monitoring". Neuchâtel. 2018-09-25
Tolremo Therapeutics AG. (9/24/18). "Press Release: Tolremo Raises CHF 9 Million Series A Financing Round and Strengthens Board of Directors with Industry Experts". Zurich. 2018-09-24
Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G 2018-09-20
Lonza Group Ltd.. (9/20/18). "Press Release: Lonza Expands Ibex Solutions to Offer Complete Product Lifecycle Management in One Location". Basel. 2018-09-20
CRISPR Therapeutics AG. (9/19/18). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. 2018-09-19
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
Neurimmune AG. (9/18/18). "Press Release: Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical". Schlieren. 2018-09-18
Roche. (9/18/18). "Press Release: Roche’s NAVIFY Decision Support Portfolio Unlocks Relevant Content from Clinical Trial and Medical Publication Databases". Basel. 2018-09-18
CRISPR Therapeutics AG. (9/17/18). "Press Release: CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes". Zug, Cambridge, MA & San Diego, CA. 2018-09-17
Luciole Medical AG. (9/17/18). "Press Release: Luciole Medical Raises CHF 5.3 Million in Series A Financing for Novel Brain Monitoring Platform". Zürich. 2018-09-17
Neurimmune AG. (9/12/18). "Press Release: Neurimmune Appoints Christoph Hock as Chief Medical Officer to Lead Clinical Development". Schlieren. 2018-09-12
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. 2018-09-09
Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. 2018-09-06
Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. 2018-09-04
Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. 2018-09-03
Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. 2018-08-30
Novartis AG. (8/29/18). "Press Release: Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma". Basel. 2018-08-29
Novartis AG. (8/29/18). "Press Release: European Commission Approves Novartis Combination Therapy Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600 Mutation-positive Melanoma". Basel. 2018-08-29
Roivant Sciences GmbH. (8/28/18). "Press Release: Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder". Basel & Irvine, CA. 2018-08-28
Novartis AG. (8/27/18). "Press Release: Novartis Receives European Commission Approval of Its CAR-T Cell Therapy, Kymriah (tisagenlecleucel)". Basel. 2018-08-27
Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel. 2018-08-23
Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug. 2018-08-22
Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel. 2018-08-20
Genedata AG. (8/20/18). "Press Release: Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D". San Francisco, CA. 2018-08-20
Tecan Group Ltd.. (8/16/18). "Press Release: H1 2018 – Tecan Posts Strong Increase in Sales, Driven by Growth in the Partnering Business". Männedorf. 2018-08-16
Tecan Group Ltd.. (8/16/18). "Press Release: Tecan Accelerates Broad Genomics Strategy with the Acquisition of NuGen Technologies". Männedorf. 2018-08-16
CRISPR Therapeutics AG. (8/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-08-07
Akouos. (8/7/18). "Press Release: Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing". Boston, MA. 2018-08-07
Roche. (8/3/18). "Press Release: PRIME Designation Granted by European Medicines Agency for RG6042 for Treatment of Huntington’s Disease". Basel. 2018-08-03
Roche. (7/31/18). "Press Release: Roche Purchases Shares in Tender Offer for FMI". Basel. 2018-07-31
Novartis AG. (7/30/18). "Press Release: Novartis Marks a New Era for Migraine Patients with the EU Approval of Aimovig, a First-of-its-Kind Treatment Specifically Designed for Migraine Prevention". Basel. 2018-07-30
Metrohm. (7/27/18). "Press Release: Metrohm Acquires B&W Tek". 2018-07-27
Sanofi S.A.. (7/26/18). "Press Release: Sanofi Head of Human Resources Roberto Pucci to Retire, Company Names Caroline Luscombe to Take over October 1st". Paris. 2018-07-26
Roche. (7/26/18). "Press Release: Roche Reports Very Strong Performance in the First Half of 2018". Basel. 2018-07-26
Roche. (7/23/18). "Press Release: Roche Receives CE Mark for Its Accu-Chek Solo Micropump System". Basel. 2018-07-23
MorphoSys AG. (7/19/18). "Press Release: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Pharma Partner". Planegg & Mechelen. 2018-07-19
Roche. (7/18/18). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Tecentriq in Combination with Avastin as First-line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)". Basel. 2018-07-18
Consilium Strategic Communications Ltd.. (7/17/18). "Press Release: Consilium Strategic Communications Advises Polyphor on its Successful CHF 155 Million (c. €130 Million) Fundraise and IPO on the SIX Swiss Exchange". London. 2018-07-17
Roche. (7/17/18). "Press Release: Phase III CAPSTONE-2 Study Showed that Baloxavir Marboxil Reduced Symptoms in People at High Risk of Complications from the Flu". Basel. 2018-07-17
Polares Medical S.A.. (7/17/18). "Press Release: Polares Medical Closes a $25m Financing to Enter Clinical Validation". Lausanne & Palo Alto, CA. 2018-07-17
Polyphor Ltd.. (7/17/18). "Press Release: Polyphor Announces Listing of New Shares Related to the Convertible Loan Facility Agreement with the Wellcome Trust (Ad-hoc Announcement)". 2018-07-17
Genedata AG. (7/10/18). "Press Release: MyBio Adopts Genedata for Improving Antibiotic Production Processes". Munich. 2018-07-10
Dynacure S.A.S.. (7/10/18). "Press Release: Dynacure Names Chris Freitag (MD) Chief Medical Officer". Strasbourg. 2018-07-10
Evolva Holding S.A.. (7/10/18). "Press Release: Evolva Announces Oliver Walker to Succeed Simon Waddington as CEO". 2018-07-10
Coulter Partners. (7/4/18). "Press Release: Coulter Partners Secures Chief Technology Officer for Basilea Pharmaceutica International Ltd.". 2018-07-04
Cytosurge AG. (6/29/18). "Press Release: Partnership between Bruker and Cytosurge – Enabling FluidFM Single Cell Experiments on the BioScope Resolve BioAFM". Zurich / Glattbrugg. 2018-06-29
NBE Therapeutics AG. (6/28/18). "Press Release: NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S". Basel. 2018-06-28
Kymab Ltd.. (6/28/18). "Press Release: Kymab and Roche Clinical Trial Agreement for KY1044". Cambridge. 2018-06-28
Bruker Corporation. (6/27/18). "Press Release: Bruker Introduces FluidFM on the BioScope Resolve BioAFM". Santa Barbara, CA. 2018-06-27
ProBioGen AG. (6/26/18). "Press Release: ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Basel. 2018-06-26
Roche. (6/22/18). "Press Release: Changes to the Roche Enlarged Corporate Executive Committee". Basel. 2018-06-22
Idorsia Ltd.. (6/20/18). "Press Release: Idorsia Initiates PRECISION Phase 3 Study with Aprocitentan for Resistant Hypertension Management". Allschwil. 2018-06-20
Novimmune S.A.. (6/20/18). "Press Release: TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody". New York, NY & Geneva. 2018-06-20
Roche. (6/19/18). "Press Release: Roche and Foundation Medicine Reach Definitive Merger Agreement to Accelerate Broad Availability of Comprehensive Genomic Profiling in Oncology". Basel. 2018-06-19
Idorsia Ltd.. (6/18/18). "Press Release: Idorsia Is Initiating REACT - Phase 3 Registration Study with Clazosentan". Allschwil. 2018-06-18
Sophia Genetics S.A.. (6/16/18). "Press Release: Sophia Genetics Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World". Milan. 2018-06-16
MorphoSys AG. (6/12/18). "Press Release: New Phase 3 Clinical Trials by MorphoSys’s Partner with Gantenerumab in Early Alzheimer's Disease now Underway". Planegg. 2018-06-12
Andrew Alliance S.A.. (6/12/18). "Press Release: Andrew Alliance Raises $14m from Top Life Sciences Industry Partners and Global Investors". Geneva. 2018-06-12
Idorsia Ltd.. (6/11/18). "Press Release: Idorsia Initiates a Phase 3 Registration Program with Nemorexant (ACT-541468) for the Treatment of Insomnia". Allschwil. 2018-06-11
Memo Therapeutics AG. (6/11/18). "Press Release: Memo Therapeutics AG Announced that Dr. Karsten Fischer Was Appointed as Chief Executive Officer of the Company Effective June 01, 2018". Basel. 2018-06-11
Nordic Nanovector ASA. (6/1/18). "Press Release: Nordic Nanovector Strengthens Management Team with Appointment of Maureen Deehan, PhD, as Head of Corporate Development and Strategy". Oslo. 2018-06-01
CRISPR Therapeutics AG. (5/30/18). "Press Release: CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease". Boston, MA, Zug & Cambridge, MA. 2018-05-30
Biognosys AG. (5/30/18). "Press Release: Introducing PQ500". 2018-05-30
Roche. (5/29/18). "Press Release: Phase III IMpower130 Study Showed Roche’s Tecentriq (atezolizumab) plus Chemotherapy (carboplatin and Abraxane) Helped People with Metastatic Non-squamous NSCLC Live Significantly Longer Compared to Chemotherapy Alone". 2018-05-29
Lunaphore Technologies S.A.. (5/24/18). "Press Release: Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets". Lausanne & Seville. 2018-05-24
Lonza Group Ltd.. (5/22/18). "Press Release: Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells". Basel. 2018-05-22
Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel. 2018-05-21
Pierre Fabre S.A.. (5/18/18). "Press Release: Pierre Fabre and Roche Extend Collaboration Agreement on Companion Diagnostic Development". Castres. 2018-05-18
Roche. (5/17/18). "Press Release: Follow-up Phase III Data Showed Roche’s Alecensa Helped People with ALK-positive Metastatic Non-Small Cell Lung Cancer Live a Median of Almost Three Years Without Their Disease Worsening or Death". Basel. 2018-05-17
Roche. (5/17/18). "Press Release: Phase III IMpower150 Study Showed Roche’s Tecentriq and Avastin plus Carboplatin and Paclitaxel Helped People with a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin plus Carboplatin 2018-05-17
Idorsia Ltd.. (5/16/18). "Press Release: Idorsia Initiates MODIFY, a Phase 3 Registration Study to Assess Lucerastat as a Potential New Treatment Option for Patients with Fabry Disease". Allschwil. 2018-05-16
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

» top